Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood, TA Pollak… - …, 2024 - academic.oup.com
Objective A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

[PDF][PDF] Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood, TA Pollak, E Massou… - 2023 - researchgate.net
Objective: A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood, TA Pollak… - …, 2023 - kclpure.kcl.ac.uk
OBJECTIVE: A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study.

M Sloan, C Wincup, R Harwood, TA Pollak… - Rheumatology …, 2023 - europepmc.org
Objective A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

[PDF][PDF] Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood, TA Pollak, E Massou… - academia.edu
Objective: A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood… - Rheumatology … - pubmed.ncbi.nlm.nih.gov
Objective A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

[HTML][HTML] Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study

M Sloan, C Wincup, R Harwood, TA Pollak… - …, 2023 - academic.oup.com
Objective A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

[PDF][PDF] Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases

M Sloan, C Wincup, R Harwood, TA Pollak, E Massou… - 2023 - research.birmingham.ac.uk
Objective: A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study.

M Sloan, C Wincup, R Harwood, TA Pollak, E Massou… - 2023 - repository.cam.ac.uk
OBJECTIVE: A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …

[PDF][PDF] Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases

M Sloan, C Wincup, R Harwood, TA Pollak, E Massou… - 2023 - pure-oai.bham.ac.uk
Objective: A limited range of neuropsychiatric symptoms have been reported in systemic
autoimmune rheumatic diseases (SARDs), with varied symptom prevalence. This study …